Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US29082K1051
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG014L7D4G1
EMBC
Embecta Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Drug Manufacturers - Specialty & Generic · THEMEFOLIO: $HLTH
NAME
Embecta Corp
ISIN
US29082K1051
TICKER
EMBC
MIC
XNAS
REUTERS
EMBC.OQ
BLOOMBERG
EMBC US
Di., 27.05.2025       Embecta
US29082K1051

PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Fr., 09.05.2025       Embecta
US29082K1051

PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six month periods ended March 31, 2025....
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Fr., 09.05.2025       Embecta
US29082K1051

PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on June 13, 2025 to stockholders of record at the close of business on May 28, 2025....
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Mo., 21.04.2025       Embecta
US29082K1051

PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Easte...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Di., 01.04.2025       Embecta
US29082K1051

The FITTER Forward Expert Recommendations are an updated set of global best practices for insulin injection technique and education....
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Di., 18.02.2025       Embecta
US29082K1051

PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta’s Chief Financial Officer, will present at the J.P. Morgan Global Leveraged Finance Conference in Miami on Tuesday, February 25, 2025 at 3:00 p.m. ET....
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Do., 06.02.2025       Embecta
US29082K1051

PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2024....
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Do., 06.02.2025       Embecta
US29082K1051

PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on March 14, 2025 to stockholders of record at the close of business on February 28, 202...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Do., 23.01.2025       Embecta
US29082K1051

PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Do., 19.12.2024       Embecta
US29082K1051

PARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 15, 2025 at 7:30 a.m. PT / 10:30 a.m. ET....
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 26.11.2024       Embecta
US29082K1051

PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month periods ended September 30, 2024....
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Di., 26.11.2024       Embecta
US29082K1051

PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on December 18, 2024 to stockholders of record at the close of business on December 6, 2...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Di., 12.11.2024       Embecta
US29082K1051

PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 fi...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Di., 12.11.2024       Embecta
US29082K1051

PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 fi...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Mo., 26.08.2024       Embecta
US29082K1051

Das Instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 27.08.2024 The instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY has its ex-dividend/interest day on 27.08.2024...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Do., 22.08.2024       Embecta
US29082K1051

PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in the following investor events:...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Fr., 09.08.2024       Embecta
US29082K1051

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2024....
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Fr., 09.08.2024       Embecta
US29082K1051

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on September 13, 2024 to stockholders of record at the close of business on August 27, 2...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Do., 18.07.2024       Embecta
US29082K1051

PARSIPPANY, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal third quarter 2024 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Do., 23.05.2024       Embecta
US29082K1051

Das Instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 24.05.2024 The instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY has its ex-dividend/interest day on 24.05.2024...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 22.05.2024       Embecta
US29082K1051

Das Instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 23.05.2024 und ex Dividende/Zinsen am 24.05.2024 The instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY has its pre-dividend/interest day on 23.05.2024 and its ex-dividend/interest day on 24.05.2024...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Do., 09.05.2024       Embecta
US29082K1051

PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on June 14, 2024 to stockholders of record at the close of business on May 28, 2024....
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Fr., 03.02.2023       Embecta
US29082K1051

New York, New York--(Newsfile Corp. - February 2, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Embecta and certain...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Sa., 07.01.2023       Embecta
US29082K1051

New York, New York--(Newsfile Corp. - January 7, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Embecta and certain o...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink
Fr., 06.01.2023       Embecta
US29082K1051

Los Angeles, California--(Newsfile Corp. - January 6, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or "the Company") (NASDAQ: EMBC) for violations of the securities laws.The investigation focuses on whether the Company issued...
Zur Nachricht
Embecta
Charts & Research Termsheets Terminal
Permalink